Nxera Pharma Market Cap

Nxera Pharma has a market cap or net worth of 92.47 billion as of June 2, 2026. Its market cap has increased by 14.15% in one year.

Market Cap

92.47B

Enterprise Value

136.70B

Revenue

34.23B

Ranking

n/a

PE Ratio

n/a

Stock Price

957.00

Market Cap Chart

Since July 29, 2004, Nxera Pharma's market cap has increased from 38.40B to 92.47B, an increase of 140.82%. That is a compound annual growth rate of 4.10%.

Market Cap History

Date	Market Cap	% Change
Jun 2, 2026	92.47B	23.55%
Dec 30, 2025	74.84B	-20.57%
Dec 30, 2024	94.22B	-25.87%
Dec 29, 2023	127.10B	-27.43%
Dec 30, 2022	175.15B	12.85%
Dec 30, 2021	155.21B	7.00%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PeptiDream	143.04B
GNI Group	141.95B
Takara Bio	137.51B
SanBio Company	111.44B
Oncolys BioPharma	80.97B
Healios K.K.	45.23B
Cuorips	40.92B
Japan Tissue Engineering	25.02B

Market Cap Rankings